false --07-31 2026 Q3 0001681769 0001681769 2025-08-01 2026-04-30 0001681769 2026-05-13 0001681769 2026-04-30 0001681769 2025-07-31 0001681769 2026-02-01 2026-04-30 0001681769 2025-02-01 2025-04-30 0001681769 2024-08-01 2025-04-30 0001681769 us-gaap:CommonStockMember 2024-07-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2024-07-31 0001681769 us-gaap:RetainedEarningsMember 2024-07-31 0001681769 2024-07-31 0001681769 us-gaap:CommonStockMember 2024-10-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2024-10-31 0001681769 us-gaap:RetainedEarningsMember 2024-10-31 0001681769 2024-10-31 0001681769 us-gaap:CommonStockMember 2025-01-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2025-01-31 0001681769 us-gaap:RetainedEarningsMember 2025-01-31 0001681769 2025-01-31 0001681769 us-gaap:CommonStockMember 2025-07-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2025-07-31 0001681769 us-gaap:RetainedEarningsMember 2025-07-31 0001681769 us-gaap:CommonStockMember 2025-10-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2025-10-31 0001681769 us-gaap:RetainedEarningsMember 2025-10-31 0001681769 2025-10-31 0001681769 us-gaap:CommonStockMember 2026-01-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2026-01-31 0001681769 us-gaap:RetainedEarningsMember 2026-01-31 0001681769 2026-01-31 0001681769 us-gaap:CommonStockMember 2024-08-01 2024-10-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2024-08-01 2024-10-31 0001681769 us-gaap:RetainedEarningsMember 2024-08-01 2024-10-31 0001681769 2024-08-01 2024-10-31 0001681769 us-gaap:CommonStockMember 2024-11-01 2025-01-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2024-11-01 2025-01-31 0001681769 us-gaap:RetainedEarningsMember 2024-11-01 2025-01-31 0001681769 2024-11-01 2025-01-31 0001681769 us-gaap:CommonStockMember 2025-02-01 2025-04-30 0001681769 us-gaap:AdditionalPaidInCapitalMember 2025-02-01 2025-04-30 0001681769 us-gaap:RetainedEarningsMember 2025-02-01 2025-04-30 0001681769 us-gaap:CommonStockMember 2025-08-01 2025-10-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2025-08-01 2025-10-31 0001681769 us-gaap:RetainedEarningsMember 2025-08-01 2025-10-31 0001681769 2025-08-01 2025-10-31 0001681769 us-gaap:CommonStockMember 2025-11-01 2026-01-31 0001681769 us-gaap:AdditionalPaidInCapitalMember 2025-11-01 2026-01-31 0001681769 us-gaap:RetainedEarningsMember 2025-11-01 2026-01-31 0001681769 2025-11-01 2026-01-31 0001681769 us-gaap:CommonStockMember 2026-02-01 2026-04-30 0001681769 us-gaap:AdditionalPaidInCapitalMember 2026-02-01 2026-04-30 0001681769 us-gaap:RetainedEarningsMember 2026-02-01 2026-04-30 0001681769 us-gaap:CommonStockMember 2025-04-30 0001681769 us-gaap:AdditionalPaidInCapitalMember 2025-04-30 0001681769 us-gaap:RetainedEarningsMember 2025-04-30 0001681769 2025-04-30 0001681769 us-gaap:CommonStockMember 2026-04-30 0001681769 us-gaap:AdditionalPaidInCapitalMember 2026-04-30 0001681769 us-gaap:RetainedEarningsMember 2026-04-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 30, 2026

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. 333-213698

BRILLIANT N.E.V. CORP.

(Exact name of registrant as specified in its charter)

Nevada	30-0944559
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

Room 805, West Building 4, Xintiandi Business Center,

Gongshu District, Hangzhou City, Zhejiang Province, China 95035

(Address of principal executive offices)

Registrant’s telephone number, including area code: +86-189-1098-4577

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of May 13, 2026, there were 153,105,464 shares of Common Stock, $0.001 par value per share, outstanding.

Table of Contents

PART I – FINANCIAL INFORMATION	3

Item 1. Financial Statements	3

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	4

Item 3. Quantitative and Qualitative Disclosures About Market Risk	5

Item 4. Controls and Procedures	5

PART II – OTHER INFORMATION	6

Item 1. Legal Proceedings	6

Item 1A. Risk Factors	6

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	6

Item 3. Defaults Upon Senior Securities	6

Item 4. Mine Safety Disclosures	6

Item 5. Other Information	6

Item 6. Exhibits	7

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

BRILLIANT N.E.V. CORP.

INDEX TO CONDENSED FINANCIAL STATEMENTS

Condensed Balance Sheets as of April 30, 2026 (Unaudited) and July 31, 2025 (Audited)	F-1

Condensed Statements of Operations for the Three and Nine Months Ended April 30, 2026 and 2025 (Unaudited)	F-2

Condensed Statement of Changes in Stockholders’ Deficit for the Nine Months Ended April 30, 2026 and 2025 (Unaudited)	F-3

Condensed Statements of Cash Flows for the Nine Months Ended April 30, 2026 and 2025 (Unaudited)	F-4

Notes to Condensed Financial Statements (Unaudited)	F-5

Table of Contents

BRILLIANT N.E.V. CORP.

BALANCE SHEETS

(Unaudited)


	April 30, 2026			July 31, 2025

ASSETS

CURRENT ASSETS
Cash	$	3,059		$	5,748
Prepaid expense		-			99
Total current assets		3,059			5,847

TOTAL ASSETS	$	3,059		$	5,847

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

CURRENT LIABILITIES

Accounts payable	$	99		$	-
Loans from related party		59,304			49,145
Total current liabilities		59,403			49,145

TOTAL LIABILITIES		59,403			49,145

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS’ EQUITY (DEFICIT)
Common stock, $0.001 par value; authorized 345,000,000 shares; 153,105,464 shares issued and outstanding at April 30, 2026 and July 31, 2025		153,105			153,105
Additional paid-in capital		114,333			114,333
Accumulated deficit		(323,782	)		(310,736	)

TOTAL EQUITY (DEFICIT)		(56,344	)		(43,298	)
TOTAL LIABILITIES AND EQUITY (DEFICIT)	$	3,059		$	5,847

The accompanying notes are an integral part of these financial statements.

F-1

Table of Contents

BRILLIANT N.E.V. CORP.

STATEMENTS OF OPERATIONS

(Unaudited)


	For the three months ended						For the nine months ended
	April 30, 2026			April 30, 2025			April 30, 2026			April 30, 2025

Revenues	$	-		$	-		$	-		$	-
Cost of goods sold		-			-			-			-
Gross profit (loss)		-			-			-			-

EXPENSES
Professional fees		10,659			-			10,659			-
General and administrative expenses		1,367			500			2,387			1,526
Total operating expenses		12,026			500			13,046			1,526

LOSS FROM CONTINUING OPERATIONS		(12,026	)		(500	)		(13,046	)		(1,526	)
LOSS FROM DISCONTINUED OPERATIONS		-			-			-			-
Net loss before tax		(12,026	)		(500	)		(13,046	)		(1,526	)
Provision for income taxes		-			-			-			-
NET LOSS	$	(12,026	)	$	(500	)	$	(13,046	)	$	(1,526	)
NET LOSS PER COMMON SHARE FROM OPERATIONS - BASIC & DILUTED	$	-		$	-		$	-		$	-
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC & DILUTED		153,105,464			153,105,464			153,105,464			153,105,464

The accompanying notes are an integral part of these financial statements.

F-2

Table of Contents

BRILLIANT N.E.V. CORP.

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT

For the nine months ended April 30, 2026 and 2025

(Unaudited)


	Common Stock				Additional Paid in		Accumulated			TOTAL
	Share		Amount		Capital		Deficit
Balance, July 31, 2024		153,105,464	$	153,105	$	114,333	$	(308,710	)	$	(41,272	)
Net Loss		-		-		-		(500	)		(500	)
Balance, October 31, 2024		153,105,464	$	153,105		114,333		(309,210	)		(41,772	)
Net Loss		-		-		-		(526	)		(526	)
Balance, January 31, 2025		153,105,464	$	153,105		114,333		(309,736	)		(42,798	)
Net Loss		-		-		-		(500	)		(500	)
Balance, April 30, 2025		153,105,464	$	153,105	$	114,333	$	(310,236	)	$	(42,798	)

Balance, July 31, 2025		153,105,464	$	153,105	$	114,333	$	(310,736	)	$	(43,298	)
Net Loss		-		-		-		(498	)		(498	)
Balance, October 31, 2025		153,105,464	$	153,105	$	114,333		(311,234	)		(43,796	)
Net Loss		-		-		-		(522	)		(522	)
Balance, January 31, 2026		153,105,464	$	153,105	$	114,333		(311,756	)		(44,318	)
Net Loss		-		-		-		(12,026	)		(12,026	)
Balance, April 30, 2026		153,105,464	$	153,105	$	114,333	$	(323,782	)	$	(56,344	)

The accompanying notes are an integral part of these financial statements.

F-3

Table of Contents

BRILLIANT N.E.V. CORP.

CASH FLOW

(Unaudited)


	For the nine months ended
	April 30, 2026			April 30, 2025
Operating activities
Net loss	$	(13,046	)		(1,526	)
Changes in assets and liabilities:
Prepaid expenses		99			-
Accounts payable		99			(99	)
Net cash used in operating activities		(12,848	)		(1,625	)

Financing activities
Loans from related party		10,159			-
Total net cash provided by financing activities		10,159			-

Net increase in cash		(2,689	)		(1,625	)

Cash at beginning of period	$	5,748		$	7,972

Cash at end of the period	$	3,059		$	6,347

The accompanying notes are an integral part of these financial statements.

F-4

Table of Contents

BRILLIANT N.E.V. CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

Brilliant N.E.V. Corp. (formerly Clancy Corp.) (the “Company”) was incorporated in the State of Nevada on March 22, 2016. Except where the context otherwise requires, references to the “Company” include its subsidiaries.

In April 2020, the Company established Shanghai Clancy Enterprise Management Co., Ltd. (“Shanghai Clancy”), a wholly foreign-owned enterprise in Shanghai, China. Shanghai Clancy subsequently established Beijing Clancy Information Technology Co., Ltd. (“Beijing Clancy”) as its wholly owned subsidiary in Beijing, China.

The Company previously operated in China through its subsidiaries. In June 2023, in connection with a change in control of the Company pursuant to a stock purchase agreement, the Company ceased the operations of its China subsidiaries. In October 2023, the Company, Shanghai Clancy, and Hongshan Yuanda Limited entered into an agreement pursuant to which all of the Company’s rights, title and interest in and to Shanghai Clancy, including its ownership of Beijing Clancy, were transferred to Hongshan Yuanda Limited, effective as of June 30, 2023. As of the effective date of the transfer, Shanghai Clancy had no operations and no assets, and all liabilities were assigned to the transferee.

In July 2023, the Company changed its name from Clancy Corp. to Brilliant N.E.V. Corp.

As of April 30, 2026, the Company had not commenced any new business operations and remained a shell company, with no or only nominal operations and nominal assets other than cash.

NOTE 2 – GOING CONCERN

The accompanying unaudited condensed financial statements have been prepared assuming that the Company will continue as a going concern. For the nine months ended April 30, 2026, the Company incurred a net loss, had an accumulated deficit, and experienced negative cash flows from operating activities. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Management intends to address these conditions through capital raising efforts, related-party support, and the pursuit of suitable business opportunities or strategic transactions. However, there can be no assurance that the Company will be successful in these efforts.

NOTE 3 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), the instructions to Form 10-Q, and Rule 10-01 of Regulation S-X. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation of the interim financial statements have been included. The results of operations for the three and nine months ended April 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending July 31, 2026 or for any future interim period.

These unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

The Company’s fiscal year end is July 31.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

F-5

Table of Contents

Income Taxes

Income taxes are accounted for using the asset and liability method. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. As of April 30, 2026, the Company had not commenced new business operations and did not recognize revenue during the three and nine months then ended.

Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. The Company had cash and cash equivalents of $3,059 and $5,748 as of April 30, 2026 and July 31, 2025, respectively.

Basic and Diluted Net Loss Per Share

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net loss per share is the same as basic net loss per share for the periods presented because any potentially dilutive instruments would be anti-dilutive.

No Material Changes in Significant Accounting Policies

There have been no material changes to the Company’s significant accounting policies from those disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

NOTE 4 – RELATED PARTY TRANSACTIONS

The Company’s Chief Financial Officer has funded the Company from time to time for working capital and operating expenses on an as-needed basis. As of April 30, 2026 and July 31, 2025, the amounts due to the Chief Financial Officer were $59,304 and $49,145, respectively. These advances were unsecured, non-interest bearing, and due on demand.

NOTE 5 – INCOME TAXES

The Company accounts for income taxes in accordance with ASC 740, Income Taxes. As of April 30, 2026, management believes that it is more likely than not that the Company’s deferred tax assets, if any, will not be realized, and accordingly a full valuation allowance has been recorded against such deferred tax assets. The Company did not record a material income tax provision for the three and nine months ended April 30, 2026. As of April 30, 2026 and July 31, 2025, the Company had net operating loss carryforwards of approximately $323,782 and $310,736, respectively, for U.S. federal income tax purposes.

NOTE 6 – SUBSEQUENT EVENTS

Management has evaluated subsequent events through May 13, 2026, the date the financial statements were available to be issued. Based on this evaluation, the Company has determined that there were no material subsequent events requiring recognition or disclosure in these financial statements, except as disclosed elsewhere in this Quarterly Report on Form 10-Q.

F-6

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the unaudited condensed financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

Overview

The Company had no operating revenue during the three and nine months ended April 30, 2026. As of April 30, 2026, the Company had not commenced any new business operations and remained a shell company, with no or only nominal operations and nominal assets other than cash. The Company is evaluating potential business opportunities, but as of April 30, 2026 had not entered into any transaction that resulted in a change in its shell company status.

Results of Operations

Three Months Ended April 30, 2026 Compared to Three Months Ended April 30, 2025

The Company did not generate any revenue during the three months ended April 30, 2026 or April 30, 2025. Operating expenses for the three months ended April 30, 2026 were $12,026, compared to $526 for the comparable prior-year period. The Company reported a net loss of $12,026 for the three months ended April 30, 2026, compared to a net loss of $526 for the three months ended April 30, 2025. The increase was primarily attributable to higher professional and administrative expenses.

Nine Months Ended April 30, 2026 Compared to Nine Months Ended April 30, 2025

The Company did not generate any revenue during the nine months ended April 30, 2026 or April 30, 2025. Operating expenses for the nine months ended April 30, 2026 were $13,046, compared to $1,026 for the comparable prior-year period. The Company reported a net loss of $13,046 for the nine months ended April 30, 2026, compared to a net loss of $1,026 for the nine months ended April 30, 2025. The increase was primarily attributable to higher professional and administrative expenses.

Liquidity and Capital Resources

As of April 30, 2026, the Company had cash and cash equivalents of $3,059, compared to $5,748 as of July 31, 2025. The Company had limited cash and working capital and had not generated revenue from operations.

Net cash used in operating activities during the nine months ended April 30, 2026 was $12,848 and was primarily attributable to the Company’s net loss and changes in working capital. Net cash provided by financing activities during the nine months ended April 30, 2026 was $10,159, consisting of advances from a related party.

The accompanying unaudited condensed financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred recurring losses, has an accumulated deficit, has experienced negative cash flows from operating activities, and has limited cash resources. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

The Company’s ability to continue as a going concern is dependent upon its ability to raise additional capital, obtain continued related-party support, reduce expenses, and ultimately achieve profitable operations through a business combination, acquisition, or other strategic transaction. There can be no assurance that the Company will be successful in obtaining additional funding or completing a transaction that generates operations.

Off-Balance Sheet Arrangements

As of April 30, 2026, the Company did not have any off-balance sheet arrangements, as defined in Item 303 of Regulation S-K, that have had, or are reasonably likely to have, a current or future material effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. There have been no material changes in the Company’s critical accounting policies and estimates from those disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, the Company is not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Management, with the participation of the Company’s principal executive officer and principal financial officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of April 30, 2026. Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were not effective as of April 30, 2026 because of material weaknesses in the Company’s internal control over financial reporting. These material weaknesses included a lack of sufficient personnel with appropriate accounting and financial reporting expertise, inadequate segregation of duties, and limited written policies and procedures necessary to achieve complete, accurate and timely financial reporting.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting during the quarter ended April 30, 2026 that materially affected, or were reasonably likely to materially affect, the Company’s internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

There are no material pending legal proceedings to which the Company is a party, and to the knowledge of management, no such proceedings are threatened against the Company, except as previously disclosed in the Company’s filings with the Securities and Exchange Commission.

Item 1A. Risk Factors

As a smaller reporting company, the Company is not required to provide the information required by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

During the quarter ended April 30, 2026, none of the Company’s directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408 of Regulation S-K.

Item 6. Exhibits

31.1	Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2	Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1	Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

32.2	Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

Filed herewith.

Furnished herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 13, 2026

BRILLIANT N.E.V. CORP.

(Registrant)

By:	/s/ Guangzhe Su
Name:	Guangzhe Su
Title:	Chief Executive Officer
	(Principal Executive Officer)

By:	/s/ Xiangying Meng
Name:	Xiangying Meng
Title:	Chief Financial Officer
	(Principal Financial Officer)

BRILLIANT N.E.V. CORP. 10-Q